Samsung Electronics, SK Hynix 2x Leverage... Will it be a negative for KOSDAQ? Only one last spark of hope remains

Summary

CEO Lee Kwon-hee discusses the strong rally in Samsung Electronics and SK Hynix driven by semiconductor demand and the launch of 2x leverage ETFs. He notes KOSDAQ underperformance, particularly biotech, and highlights DND Pharmatech as a binary event play on ASCO data. The video also covers valuation of Samsung Electronics, sector rotation, and the limited impact of the National Growth Fund.

• Samsung Electronics and SK Hynix surge 7% and 11% respectively, boosting KOSPI but not KOSDAQ.
• Newly listed 2x leverage single-stock ETFs on Samsung Electronics see massive inflows, led by KODEX.
• KOSDAQ falls 0.69% as biotech stocks decline despite National Growth Fund expectations.
• DND Pharmatech's upcoming ASCO data release is a key binary event for the biotech sector.
• Lee notes Samsung Electronics' forward P/E of 5-6x is historically cheap but does not give a clear buy signal.
• Semiconductor equipment stocks like Eugene Technology and Wonik are mentioned as potential laggard plays.
• Foreign investors show mixed behavior, selling futures while buying spot, suggesting hedging or profit-taking.
• The video emphasizes the need to study market flows and invest actively in the current volatile environment.